News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|January 28, 2022

Acne’s Unseen Pain

Speaking from their unique perspectives, physicians and a psychologist share their success strategies for opening a dialogue with pediatric patients and their families about acne’s sometimes devastating impact on their mental wellbeing and quality of life, danger signals to watch, and why the term “bullying” has no place in the conversation.

Episodes in this series

EP. 1 Meet the Experts

EP. 1 Meet the Experts

EP. 2 Patient Assessment: Get the Patient’s History, Then Get Their Story

EP. 2 Patient Assessment: Get the Patient’s History, Then Get Their Story

EP. 3 Tackling Tough Issues: How to Talk to Patients and Their Families

EP. 3 Tackling Tough Issues: How to Talk to Patients and Their Families

EP. 4 Next-level Diagnosis and Compliance

EP. 4 Next-level Diagnosis and Compliance

EP. 5 Acne’s Unseen Pain

EP. 5 Acne’s Unseen Pain

EP. 6 What’s New?

EP. 6 What’s New?

EP. 7 Q&A

EP. 7 Q&A

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD

Julie Khlevner, MD, AGAF, explains the impact of the FDA approval of linaclotide for pediatric IBS-C

Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency

Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children

Linaclotide demonstrates positive long-term safety

© 2025 MJH Life Sciences^®

All rights reserved.